Predicting response to bacillus Calmette-Guérin: time to look beyond the ages

Affiliations

¹ The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org.
² BCG Oncology, Phoenix, AZ, USA.

Editorial

Ashish M Kamat et al. Eur Urol. 2014 Oct.

. 2014 Oct;66(4):702-3.

doi: 10.1016/j.eururo.2014.06.008. Epub 2014 Jun 23.

¹ The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org.
² BCG Oncology, Phoenix, AZ, USA.

No abstract available

Comment on

The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
Oddens JR, Sylvester RJ, Brausi MA, Kirkels WJ, van de Beek C, van Andel G, de Reijke TM, Prescott S, Witjes JA, Oosterlinck W. Oddens JR, et al. Eur Urol. 2014 Oct;66(4):694-701. doi: 10.1016/j.eururo.2014.05.033. Epub 2014 Jun 16. Eur Urol. 2014. PMID: 24948466 Clinical Trial.